NCT06233942 2026-03-18Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid TumorsBeOne MedicinesPhase 1 Recruiting308 enrolled